Company intelligence / Profile preview

Indiabulls Pharmaceuticals

New Delhi, Delhi, India

Ownership: Private
Development stage: Other

Overview

Indiabulls Pharmaceuticals has launched nearly 300 branded generic and specialty pharmaceutical products covering major therapy areas. Products are manufactured via WHO/EU GMP certified contract partners and widely distributed in India. There are no reported novel drug clinical trials or data on new molecular entities.

Therapeutic areas: EndocrinologyMetabolic DisordersInfectious DiseasesDermatologyCardiovascularOtherWomen's Health
Modalities: Small molecule
Industry: Biotech

Partnerships

Clermont Group (investor/partner, Singapore)Multiple contract manufacturing partners (unnamed)

Beyond the preview

Go deeper on Indiabulls Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indiabulls Pharmaceuticals.

Explore the full profile